Peer Review History

Original SubmissionAugust 26, 2025
Decision Letter - Miquel Vall-llosera Camps, Editor

Dear Dr. Mensah,

Thank you for submitting your manuscript to PLOS One. Firstly, we would like to apologize for the delay in processing your manuscript. It has been exceptionally difficult to secure reviewers to evaluate your study. We have now received one completed review, which is available below. The reviewer has raised significant scientific concerns about the study that need to be addressed in a revision.

Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. 

Please submit your revised manuscript by Dec 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Miquel Vall-llosera Camps

Senior Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: 1. The research design aligns with the study aim of understanding intraoperative surgical site infection (SSI) prevention practices among nurses in a tertiary hospital. The use of semi-structured interviews and thematic analysis is suitable for the exploratory nature of the work.

The data collection procedures are adequately described, and the inclusion of direct participant quotations supports the authenticity of the findings. However, the analytic process lacks sufficient transparency. There is minimal description of the coding framework, how the codes were developed, refined and integrated into the themes. Although NVivo software is mentioned, its role in data management or theme generation is not clearly explained.

The findings and conclusions are largely consistent, with the data supporting the main claims about infection prevention practices, supervision, and resource challenges. However there is overgeneralization —for example, “multidisciplinary collaboration significantly reduces SSIs” that extends beyond what qualitative data can demonstrate.

There should be explicit documentation of ethics approval (e.g., institutional review board reference number).

Overall, the manuscript requires greater methodological transparency and moderation of inferential claims to fully substantiate its conclusions.

2. The manuscript provides only a superficial description of the analytic process: It lists Braun & Clarke’s phases but does not show how themes were derived from codes. There are no sample codes, codebooks, or excerpts to illustrate analytic progression. The process of reflexivity and peer debriefing is mentioned but not demonstrated with examples. while the method is suitable, the reporting of its application lacks depth and transparency.

3. No details on inter-coder reliability or peer validation (e.g., whether another researcher cross-checked coding).

No clear evidence of data triangulation or how saturation was confirmed. There is Over-reliance on researcher interpretation without documented audit examples.

4. The manuscript lacks frequency indicators for reporting prevalence without quantifying. There is no comparative analysis (e.g., by role, experience, or theatre vs ward) explored, which could have added analytic richness.

5. The manuscript does not include a Data Availability Statement, nor does it indicate where the underlying qualitative data (e.g., anonymized transcripts, coding framework) are deposited.

6. The manuscript is presented in an intelligible and well-structured manner overall. The English is clear though minor grammatical and stylistic issues should be addressed g. Some sentences are overly long or repetitive,

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures 

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. 

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Revision 1

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

The manuscript have been revised to meet PLOS ONE's style requirements.

2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

The ethics statements have been moved to the methods section of the manuscript as recommended. (Page 9)

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

4. The relevant anonnymised data have been provided in the manuscript. (Pages 10-21)

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide4.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Thank you

1. The research design aligns with the study aim of understanding intraoperative surgical site infection (SSI) prevention practices among nurses in a tertiary hospital. The use of semi-structured interviews and thematic analysis is suitable for the exploratory nature of the work.

The authors are grateful for the feedback.

2. The data collection procedures are adequately described, and the inclusion of direct participant quotations supports the authenticity of the findings. However, the analytic process lacks sufficient transparency. There is minimal description of the coding framework, how the codes were developed, refined and integrated into the themes. Although NVivo software is mentioned, its role in data management or theme generation is not clearly explained.

The analytical processes used have been provided as recommended.

The table of themes, sub-themes and codes have been provided to show how codes were developed, refined and integrated into the final themes. (Pages 7 & 8)

3. The findings and conclusions are largely consistent, with the data supporting the main claims about infection prevention practices, supervision, and resource challenges. However there is overgeneralization —for example, “multidisciplinary collaboration significantly reduces SSIs” that extends beyond what qualitative data can demonstrate.

We are grateful for this feedback. The overgeneralizing statements have been revised and limited to the qualitative data in the study (page 3)

4.There should be explicit documentation of ethics approval (e.g., institutional review board reference number).

Overall, the manuscript requires greater methodological transparency and moderation of inferential claims to fully substantiate its conclusions.

The institutional review board reference number was provided in the first document under Declarations section (Ethical Approval and Consent to participate). It has now been moved to the methods section. (Page 9)

5. The manuscript provides only a superficial description of the analytic process: It lists Braun & Clarke’s phases but does not show how themes were derived from codes. There are no sample codes, codebooks, or excerpts to illustrate analytic progression. The process of reflexivity and peer debriefing is mentioned but not demonstrated with examples. while the method is suitable, the reporting of its application lacks depth and transparency.

We appreciate this feedback. A more detailed description of how themes (and sub-themes) were derived from codes have been provided as recommended. The process of reflexivity and peer debriefing has also been detailed. (Pages 7, 8 & 9,

12,13 & 14).

6. No details on inter-coder reliability or peer validation (e.g., whether another researcher cross-checked coding).

No clear evidence of data triangulation or how saturation was confirmed. There is Over-reliance on researcher interpretation without documented audit examples.

Additional details have been provided regarding peer validation, particularly how the other researchers cross-checked the preliminary coding.We have added that saturation was confirmed by conducting 2 additional interviews beyond the point where participants’ feedback became repetitive, additional interviews were not yielding new insights to add up to the themes and sub-themes. (6, 8 & 9)

7. The manuscript lacks frequency indicators for reporting prevalence without quantifying. There is no comparative analysis (e.g., by role, experience, or theatre vs ward) explored, which could have added analytic richness.

We are grateful for this feedback. As recommended, we will explore these comparative analysis in follow-up studies to enhance the analytic richness.

8. The manuscript does not include a Data Availability Statement, nor does it indicate where the underlying qualitative data (e.g., anonymized transcripts, coding framework) are deposited.

The Data Availability Statement was provided in the manuscript (page 20) under the declarations section (Availability of data and materials). (Page 25)

9. The manuscript is presented in an intelligible and well-structured manner overall. The English is clear though minor grammatical and stylistic issues should be addressed. Some sentences are overly long or repetitiveWe are grateful for the feedback.

We have reduced the overly long or repetitive sentences as recommended. Grammatical errors have been corrected. (Page 23)

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Nan Jiang, Editor

Sepsis under pressure, intraoperative surgical site infection prevention practices among nurses in emergency surgical settings: A qualitative study

PONE-D-25-42877R1

Dear Dr. Mensah,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nan Jiang

Academic Editor

PLOS One

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: All the comments previously raised have been addressed by the authors with improvements in the methodology thereby strengthening the manuscript

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Nan Jiang, Editor

PONE-D-25-42877R1

PLOS One

Dear Dr. Mensah,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nan Jiang

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .